Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...
Tenaya’s Highly Selective HDAC6 Inhibitor TN-301 Outperformed Approved Pan-HDAC Inhibitor Givinostat in Improving Muscle Function and Correcting ...
New injection helps body produce heart protecting hormone for weeks after heart attack, improving recovery potential.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results